Use of decision analysis to evaluate the costs and benefits of filgrastim (G-CSF) therapy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      FILGRASTIM; DRUG therapy; NEUTROPHILS
    • Abstract:
      Evaluates the costs the benefits of the use of filgrastim (granulocyte colony-stimulating factor [G-CSF]) in the treatment of neutrophil counts after chemotherapy. Use of the quantitative method of decision analysis; Principles of decision analysis; Operation mechanics of the study; Recommendations.